Literature DB >> 28360632

Effects of Dimensional and Categorical Classification on the Clinical Manifestation of Major Depressive Disorder.

Hüseyin Güleç1, Aytül Karabekİroğlu2, Aynil Yenel1, Mustafa Burak Baykaran1, Elif Keleş Ünal3.   

Abstract

INTRODUCTION: The aim of this study was to combine the dimensional concept with the categorical system in major depressive disorder (MDD) to reduce the complexity of the diagnosis. Furthermore, it was aimed to match categorical and dimensional approaches in a clear and simple manner.
METHOD: The study included a patient group of 131 consecutive outpatients diagnosed with MDD according to the DSM-IV diagnosis criteria, and a control group of 99 people that is matched with the patient group by gender, age and education level. All subjects completed the Beck Depression Inventory, the Beck Anxiety Inventory and the Toronto Alexithymia Scale (TAS).
RESULTS: Cronbach's alpha values for the analysis of the internal consistency of the scale for the patients group, control group and the total participants were determined as .94-.97, .87-.92 and .93-.96, respectively. Nine factors were obtained from the results of exploratory factor analysis. According to the Scree-plot, it was decided that the two-factor structure represents best. Although depression and anxiety are two distinct dimensions, the relationship between them was found to be significantly significant. This was valid for both patient and control groups. When the relationship between the DSM-IV diagnosis criteria and all variables (depression and its sub-dimensions, anxiety and its sub-dimensions and the number of symptoms) was evaluated, the number of symptoms was found to be significantly related with all of the criteria.
CONCLUSION: The number of symptoms and the severity of illness are found to be important in the clinical manifestation of MDD. The relationship of the severity of the illness with sleep and appetite seems weaker. While loss of interest was mainly predicting the disorder, weight changes, psychomotor changes, difficulty in concentration, fatigue, and worthlessness were determined not to be predictors of the manifestations. According to dimensional approach, somatic anxiety and deterioration in performance predict the presence of the disorder. According to categorical and dimensional approaches, some of the DSM-IV criteria (#2, #1, #9, #4, number of symptoms, severity of symptoms, somatic anxiety, performance deterioration) are seen to contribute to the matchability between the approaches.

Entities:  

Keywords:  Depression; alexithymia; anxiety; categorical approach; dimensional approach

Year:  2014        PMID: 28360632      PMCID: PMC5353129          DOI: 10.4274/npa.y6834

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  18 in total

1.  Burden of disease--implications for future research.

Authors:  C M Michaud; C J Murray; B R Bloom
Journal:  JAMA       Date:  2001-02-07       Impact factor: 56.272

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  Diagnosing major depressive disorder VIII: are some symptoms better than others?

Authors:  Joseph B McGlinchey; Mark Zimmerman; Diane Young; Iwona Chelminski
Journal:  J Nerv Ment Dis       Date:  2006-10       Impact factor: 2.254

4.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

5.  The twenty-item Toronto Alexithymia Scale--I. Item selection and cross-validation of the factor structure.

Authors:  R M Bagby; J D Parker; G J Taylor
Journal:  J Psychosom Res       Date:  1994-01       Impact factor: 3.006

6.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

7.  Diagnosing major depressive disorder III: can some symptoms be eliminated from the diagnostic criteria?

Authors:  Mark Zimmerman; Joseph B McGlinchey; Diane Young; Iwona Chelminski
Journal:  J Nerv Ment Dis       Date:  2006-05       Impact factor: 2.254

8.  Hopelessness depression as a distinct dimension of depressive symptoms among clinical and non-clinical samples.

Authors:  T E Joiner; R A Steer; L Y Abramson; L B Alloy; G I Metalsky; N B Schmidt
Journal:  Behav Res Ther       Date:  2001-05

9.  Diagnosing major depressive disorder I: A psychometric evaluation of the DSM-IV symptom criteria.

Authors:  Mark Zimmerman; Joseph B McGlinchey; Diane Young; Iwona Chelminski
Journal:  J Nerv Ment Dis       Date:  2006-03       Impact factor: 2.254

10.  Empirical investigation of two assumptions in the diagnosis of DSM-IV major depressive episode.

Authors:  Chika Sakashita; Tim Slade; Gavin Andrews
Journal:  Aust N Z J Psychiatry       Date:  2007-01       Impact factor: 5.744

View more
  1 in total

1.  Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent Profile Analysis.

Authors:  Xiaohui Wu; Yuncheng Zhu; Zhiguo Wu; Jia Huang; Lan Cao; Yun Wang; Yousong Su; Hongmei Liu; Maosheng Fang; Zhijian Yao; Zuowei Wang; Fan Wang; Yong Wang; Daihui Peng; Jun Chen; Yiru Fang
Journal:  Front Psychiatry       Date:  2022-07-12       Impact factor: 5.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.